Anthony Sinskey
Founder at YIELD10 BIOSCIENCE, INC.
Net worth: 24 424 $ as of 2024-03-30
Profile
Anthony J.
Sinskey is the founder of Yield10 Bioscience, Inc. (founded in 1992) and Tepha, Inc. (founded in 1998).
He is currently a Director at Akeso Biomedical, Inc., SweeGen, Inc., ABEC, Inc., and the MIT Center for Biomedical Innovation.
He is also a Professor at the Massachusetts Institute of Technology since 1968.
In the past, he served as an Independent Director at Merrimack Pharmaceuticals, Inc. (founded in 1993) from 2011 to 2015.
He was also a Director at Apex Bioventures Acquisition Corp.
from 2006 to 2009 and an Advisor at Kodiak Ventures Management Company Inc. He holds a doctorate degree from the Massachusetts Institute of Technology (conferred in 1966) and an undergraduate degree from the University of Illinois.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
YIELD10 BIOSCIENCE, INC.
0.54% | 2024-03-27 | 64,274 ( 0.54% ) | 24 424 $ | 2024-03-30 |
Anthony Sinskey active positions
Companies | Position | Start |
---|---|---|
YIELD10 BIOSCIENCE, INC. | Founder | 1992-05-31 |
SWEEGEN, INC. | Director/Board Member | - |
Tepha, Inc.
Tepha, Inc. Medical SpecialtiesHealth Technology Tepha, Inc. develops and commercializes medical devices and biomaterial technology. The firm’s products include monofilament suture, monofilament mesh, surgical film and composite mesh. The company was founded by Anthony J. Sinskey and Simon Williams in 1998 and is headquartered in Lexington, MA. | Founder | 1997-12-31 |
Massachusetts Institute of Technology | Corporate Officer/Principal | 1967-12-31 |
ABEC, Inc.
ABEC, Inc. Engineering & ConstructionIndustrial Services ABEC, Inc. is a private company that provides engineered process solutions and services for manufacturing in the biotech industry. ABEC is based in Bethlehem, PA and has subsidiaries in Ireland. The majority of the world's pharmaceutical and biotech companies are ABEC customers, with many of today's leading therapies manufactured by processes and equipment engineered, manufactured, installed, and serviced by ABEC. ABEC's unique value is based on long experience, complete in-house capabilities, a custom, flexible approach, and long-term credibility. Whether adding capacity or improving existing facilities, ABEC's turn-key solutions and support services reduce overall cost and time to market while delivering maximum productivity. The company was founded in 1974 by Jack Wilson, and the CEO is Scott Pickering. | Director/Board Member | - |
MIT Center for Biomedical Innovation
MIT Center for Biomedical Innovation Miscellaneous Commercial ServicesCommercial Services MIT Center for Biomedical Innovation improves global health by overcoming obstacles to the development and implementation of biomedical innovation. Its programs include Biomanufacturing Program, Consortium on Adventitious Agent Contamination in Biomanufacturing and New Drug Development Paradigms program. The company was founded by Frank Lennox Douglas in 2005 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Akeso Biomedical, Inc.
Akeso Biomedical, Inc. Financial ConglomeratesFinance Akeso Biomedical, Inc. develops solutions for the treatment of bacterial infections, microbial biofilms, and chronic wounds using a broad-spectrum iron complex chemistry. Its product includes Fe3C compounds for the prevention of foodborne illnesses, and the treatment of bacterial infections, including chronic wounds and medical devices. The company was founded in 2014 and is headquartered in Burlington, MA. | Director/Board Member | - |
Former positions of Anthony Sinskey
Companies | Position | End |
---|---|---|
MERRIMACK PHARMACEUTICALS, INC. | Founder | 2015-01-29 |
Apex Bioventures Acquisition Corp.
Apex Bioventures Acquisition Corp. Financial ConglomeratesFinance The Company is a blank check company. It is formed to acquire one or more domestic or foreign operating business in the healthcare industry through merger, capital stock exchange, asset acquisition or other similar business combination. The Company is in the development stage. On February 5, 2008, the Company entered into an Agreement and Plan of Merger with Dynogen Pharmaceuticals, Inc and its acting representatives. | Director/Board Member | 2009-06-03 |
░░░░░░ ░░░░░░░░ ░░░░░░░░░░ ░░░░░░░ ░░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | - |
Training of Anthony Sinskey
Massachusetts Institute of Technology | Doctorate Degree |
University of Illinois | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 3 |
---|---|
YIELD10 BIOSCIENCE, INC. | Process Industries |
MERRIMACK PHARMACEUTICALS, INC. | Health Technology |
SWEEGEN, INC. | Consumer Non-Durables |
Private companies | 6 |
---|---|
Tepha, Inc.
Tepha, Inc. Medical SpecialtiesHealth Technology Tepha, Inc. develops and commercializes medical devices and biomaterial technology. The firm’s products include monofilament suture, monofilament mesh, surgical film and composite mesh. The company was founded by Anthony J. Sinskey and Simon Williams in 1998 and is headquartered in Lexington, MA. | Health Technology |
Apex Bioventures Acquisition Corp.
Apex Bioventures Acquisition Corp. Financial ConglomeratesFinance The Company is a blank check company. It is formed to acquire one or more domestic or foreign operating business in the healthcare industry through merger, capital stock exchange, asset acquisition or other similar business combination. The Company is in the development stage. On February 5, 2008, the Company entered into an Agreement and Plan of Merger with Dynogen Pharmaceuticals, Inc and its acting representatives. | Finance |
Akeso Biomedical, Inc.
Akeso Biomedical, Inc. Financial ConglomeratesFinance Akeso Biomedical, Inc. develops solutions for the treatment of bacterial infections, microbial biofilms, and chronic wounds using a broad-spectrum iron complex chemistry. Its product includes Fe3C compounds for the prevention of foodborne illnesses, and the treatment of bacterial infections, including chronic wounds and medical devices. The company was founded in 2014 and is headquartered in Burlington, MA. | Finance |
Kodiak Ventures Management Company Inc
Kodiak Ventures Management Company Inc Investment ManagersFinance Kodiak Ventures Management Company Inc (Kodiak Venture Partners) is a venture capital firm founded in 1999 by Jim H. Furneaux and David Furneaux. The firm is headquartered in Wellesley, Massachusetts. | Finance |
ABEC, Inc.
ABEC, Inc. Engineering & ConstructionIndustrial Services ABEC, Inc. is a private company that provides engineered process solutions and services for manufacturing in the biotech industry. ABEC is based in Bethlehem, PA and has subsidiaries in Ireland. The majority of the world's pharmaceutical and biotech companies are ABEC customers, with many of today's leading therapies manufactured by processes and equipment engineered, manufactured, installed, and serviced by ABEC. ABEC's unique value is based on long experience, complete in-house capabilities, a custom, flexible approach, and long-term credibility. Whether adding capacity or improving existing facilities, ABEC's turn-key solutions and support services reduce overall cost and time to market while delivering maximum productivity. The company was founded in 1974 by Jack Wilson, and the CEO is Scott Pickering. | Industrial Services |
MIT Center for Biomedical Innovation
MIT Center for Biomedical Innovation Miscellaneous Commercial ServicesCommercial Services MIT Center for Biomedical Innovation improves global health by overcoming obstacles to the development and implementation of biomedical innovation. Its programs include Biomanufacturing Program, Consortium on Adventitious Agent Contamination in Biomanufacturing and New Drug Development Paradigms program. The company was founded by Frank Lennox Douglas in 2005 and is headquartered in Cambridge, MA. | Commercial Services |
- Stock Market
- Insiders
- Anthony Sinskey